1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow George Poultsides: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery Fluorescence Imaging, Panitumumab, Panitumumab-IRDye800 - Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | George Poultsides | 27 | 2018-02-07 | 2026-03-17 |
Optical Imaging (1) · Panitumumab (1)
United States (1)
R01CA190306 (1)